News and Insights

The latest news and insights from Genoa Healthcare.

  • Behavioral Health
  • Clinical Insights
  • Treatment

November 2023 drug trend report

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview of the latest and connect with your local...

  • Nov 1st, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

3 Trends to follow this flu season

According to the CDC, flu season runs rampant from October through May.1 Looking to keep the people you serve safe during the 2023-2024 flu season? Keep these three trends on...

  • Oct 4th, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

September 2023 drug trend report

Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Brixadi™ Zurzuvae™ (zuranolone) Generic drug...

  • Sep 1st, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

August 2023 drug trend report

Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Uzedy Abilify Asimtuffii Brixadi Generic...

  • Aug 2nd, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

Frequently asked questions: naloxone (Narcan®)

Narcan® information and sources were taken from www.narcan.com. 1. FDA Approves First Over-the-Counter Naloxone Nasal Spray. 3/29/2023. FDA Approves First Over-the-Counter Naloxone Nasal Spray | FDA

  • Mar 29th, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

Frequently asked questions: buprenorphine-containing products

Information and sources on buprenorphine-containing products were taken from www.sublocade.com and www.suboxone.com.

  • Mar 6th, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

What’s on the horizon: four emerging trends in the medication-assisted treatment space

1X-Waiver no longer need to treat opioid use disorder. (2023, January 13). ACEP. 2. Sublocade. 3.BMC launces app to help providers treat patients with opioid use disorder. (2021, March 22)....

  • Mar 6th, 2023
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: Medication-assisted Treatment: Trends and Outcomes

For consumers living with opioid use disorder (OUD), medication-assisted treatment (MAT) has become the gold standard of treatment. In a new webinar, Genoa Healthcare Director of Operations Megan Garrity, PharmD,...

  • Dec 20th, 2022
  • Behavioral Health
  • Clinical Insights

Webinar: Improving outcomes during transitions of care

In a new webinar, Genoa Directors of Operations Joseph Pellerito and Katie Lozano share how organizations are addressing risks associated with transitions of care through unique partnerships and programs to...

  • Oct 5th, 2022
  • Behavioral Health
  • Clinical Insights

Fighting stigma around substance use disorder

Words matter when you provide care for people with substance use disorder (SUD), says Genoa pharmacist Shawn Zwilling. Zwilling’s pharmacy is located onsite at the St. Louis-based Assisted Recovery Centers...

  • Sep 7th, 2022